tetano
Editor, Senior Moderator
Tremor Other Hyperkinet Mov (N Y)
. 2021 Feb 10;11:7.
doi: 10.5334/tohm.580.
Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis
Enrique Urrea-Mendoza[SUP] 1 2 [/SUP], Kimberly Okafor[SUP] 2 [/SUP], Senthuran Ravindran[SUP] 2 [/SUP], John Absher[SUP] 1 2 [/SUP], Varun Chaubal[SUP] 1 2 [/SUP], Fredy J Revilla[SUP] 1 2 [/SUP]
Affiliations
Abstract
The novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) is the cause of the COVID-19 pandemic [5]. SARS-Cov-2 demonstrates partial resemblance to SARS-CoV and MERS-CoV in phylogenetic analysis, clinical manifestations, and pathological findings [6, 7]. Reports emerging from China have described ataxia as a neurological symptom of the SARS-CoV-2 infection [5]. Opsoclonus consists of back-to-back multidirectional conjugate saccades without an inter-saccadic interval [8]. Myoclonus is defined as a sudden, brief, "shock-like", nonepileptic involuntary movement [9], which has been described as a symptom of SARS-CoV-2 infection [10]. Opsoclonus-Myoclonus-Ataxia syndrome (OMAS) associated COVID-19 infection has been reported recently [1112].
Keywords: Movement Disorders; Opsoclonus-Myoclonus Ataxia Syndrome; Post-infection; SARS-CoV-2.
. 2021 Feb 10;11:7.
doi: 10.5334/tohm.580.
Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis
Enrique Urrea-Mendoza[SUP] 1 2 [/SUP], Kimberly Okafor[SUP] 2 [/SUP], Senthuran Ravindran[SUP] 2 [/SUP], John Absher[SUP] 1 2 [/SUP], Varun Chaubal[SUP] 1 2 [/SUP], Fredy J Revilla[SUP] 1 2 [/SUP]
Affiliations
- PMID: 33614199
- PMCID: PMC7879990
- DOI: 10.5334/tohm.580
Abstract
The novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) is the cause of the COVID-19 pandemic [5]. SARS-Cov-2 demonstrates partial resemblance to SARS-CoV and MERS-CoV in phylogenetic analysis, clinical manifestations, and pathological findings [6, 7]. Reports emerging from China have described ataxia as a neurological symptom of the SARS-CoV-2 infection [5]. Opsoclonus consists of back-to-back multidirectional conjugate saccades without an inter-saccadic interval [8]. Myoclonus is defined as a sudden, brief, "shock-like", nonepileptic involuntary movement [9], which has been described as a symptom of SARS-CoV-2 infection [10]. Opsoclonus-Myoclonus-Ataxia syndrome (OMAS) associated COVID-19 infection has been reported recently [1112].
Keywords: Movement Disorders; Opsoclonus-Myoclonus Ataxia Syndrome; Post-infection; SARS-CoV-2.